Company Monitoring Page for Bausch-+-Lomb

latest headlines for company on cafepharma

After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale
Fierce Pharma
Thu, 12/12/24 - 11:47 pm
Tags:
Bausch + Lomb, M&A
TPG, Blackstone bid for Bausch + Lomb in potential $14 billion deal
Economic Times
Mon, 10/14/24 - 11:23 pm
Tags:
Bausch + Lomb, M&A, TPG, Blackstone
B+L Rumored to be Looking at Potential Sale to Fully Separate from Parent Company
Medical Devices and Diagnostics Industry
Mon, 09/16/24 - 10:26 pm
Tags:
Bausch + Lomb, Medtech, Bausch Health
Joseph Papa, after leaving Bausch, begins another turnaround project as CEO of Emergent BioSolutions
Fierce Pharma
Wed, 02/21/24 - 11:16 am
Tags:
Joseph Papa, Pharma CEOs, Emergent BioSolutions, Bausch + Lomb
Bausch + Lomb’s Faces of Glaucoma brings clarity to silent thief of sight
Medical Marketing and Media
Mon, 01/22/24 - 10:08 pm
Tags:
Bausch + Lomb, glaucoma, pharma marketing
Why Shares of Bausch Health Companies Fell Tuesday
Motley Fool
Tue, 09/19/23 - 10:17 pm
Tags:
Bausch + Lomb, Norwich Pharma Services, patents
Bausch + Lomb seeks funding for eye drug acquisition from Novartis
BioPharma Dive
Wed, 09/13/23 - 11:32 am
Tags:
Bausch + Lomb, Novartis, M&A, Xiidra
Bausch + Lomb's Saunders doesn't expect more big deals in the near term
Reuters
Fri, 08/4/23 - 10:19 am
Tags:
Bausch + Lomb, Pharma CEOs, Brent Saunders, earnings, M&A
Bausch + Lomb Buys J&J’s Dry Eye Drops for $106.5M in Expansion of OTC Business
BioSpace
Thu, 07/6/23 - 11:32 am
Tags:
Bausch + Lomb, dry eye disease, OTC, JNJ Vision
Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis
Healio
Fri, 06/30/23 - 10:10 am
Tags:
Bausch + Lomb, M&A, Novartis, Xiidra, dry eye disease
Biopharma Companies with the Biggest CEO-Employee Pay Gaps
BioSpace
Thu, 06/15/23 - 09:58 am
Tags:
Pharma CEOs, executive compensation, Sarepta Therapeutics, Pfizer, Bausch + Lomb, Amneal Pharmaceuticals, Thermo Fisher, IQVIA, McKesson, Royalty Pharma, Charles Rivers Laboratories, Seagen
Bausch + Lomb ‘reshaping’ executive team
NJ Biz
Thu, 06/1/23 - 06:29 pm
Tags:
Bausch + Lomb, executives, reorganization
FDA Approves Bausch + Lomb, Novaliq Dry Eye Disease Drug
BioSpace
Fri, 05/19/23 - 10:23 am
Tags:
Bausch + Lomb, Novaliq, Miebo, FDA, dry eye disease
Brent Saunders to Return as Bausch + Lomb CEO
US News Money
Wed, 02/15/23 - 10:58 am
Tags:
Brent Saunders, Bausch + Lomb, Joseph Papa, Pharma CEOs
B+L Set to Acquire AcuFocus in Busy M&A Month
Medical Devices and Diagnostics Industry
Tue, 01/17/23 - 11:00 pm
Tags:
Bausch + Lomb, AcuFocus, Medtech, M&A
Bausch + Lomb debuts line of eye, ear and wellness products for dogs
Medical Marketing and Media
Mon, 10/24/22 - 11:06 pm
Tags:
Bausch + Lomb, animal health, Project Watson
Venture financing holds steady for device makers
EP Vantage
Fri, 07/22/22 - 10:05 am
Tags:
devices, Medtech, venture capital, IPOs, Bausch + Lomb, Billiontoone, Biofourmis, Enable Injections, Meihua, Saluda Medical, Tenon Medical
Akorn Inc. Scores Two Generic Approvals from the FDA
BioSpace
Fri, 04/19/19 - 10:40 am
Tags:
Akorn, FDA, generics, Flonase, GSK, Lotemax, Bausch + Lomb
Valeant Pharma's (VRX) Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
Street Insider
Mon, 07/9/18 - 06:46 pm
Tags:
Valeant Pharmaceuticals, Bausch + Lomb, FDA, sub-micron loteprednol etabonate

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.